Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Booking.com
BKNG
|
+$551M |
| 2 |
Meta Platforms (Facebook)
META
|
+$407M |
| 3 |
Align Technology
ALGN
|
+$382M |
| 4 |
United Parcel Service
UPS
|
+$310M |
| 5 |
PayPal
PYPL
|
+$291M |
Top Sells
| 1 |
Apple
AAPL
|
+$598M |
| 2 |
Alibaba
BABA
|
+$570M |
| 3 |
Altria Group
MO
|
+$408M |
| 4 |
Revvity
RVTY
|
+$350M |
| 5 |
Merck
MRK
|
+$320M |
Sector Composition
| 1 | Technology | 30.77% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Discretionary | 11.52% |
| 4 | Financials | 9.59% |
| 5 | Communication Services | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Las Vegas Sands
LVS
$37.2B
| $18.5M | 0.01% |
395,683
-89,669
| -18% | -$4.18M |
|
727
BellRing Brands
BRBR
$4.65B
| $18.4M | 0.01% |
889,243
-40,747
| -4% | -$845K |
|
|
ZNGA
728
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $18.4M | 0.01% |
2,022,122
+1,608,639
| +389% | +$14.7M |
|
729
Athira Pharma
ATHA
$15.4M
| $18.1M | 0.01% |
+1,003,198
| New | +$18.1M |
|
730
Codexis
CDXS
$229M
| $18M | 0.01% |
1,529,770
+36,814
| +2% | +$432K |
|
731
US Bancorp
USB
$76.9B
| $17.9M | 0.01% |
499,702
-5,205,022
| -91% | -$187M |
|
732
Corpay
CPAY
$21.9B
| $17.8M | 0.01% |
74,625
-357,881
| -83% | -$85.2M |
|
733
Fortinet
FTNT
$61.4B
| $17.6M | 0.01% |
746,320
+18,440
| +3% | +$434K |
|
|
CMBT
734
CMB.TECH NV
CMBT
$2.71B
| $17.6M | 0.01% |
1,990,822
| – | – |
|
735
Enterprise Products Partners
EPD
$68.7B
| $17.5M | 0.01% |
1,109,517
-29,709
| -3% | -$469K |
|
|
PE
736
DELISTED
PARSLEY ENERGY INC
PE
| $17.4M | 0.01% |
1,861,845
-320,284
| -15% | -$3M |
|
737
Surmodics
SRDX
$462M
| $17.4M | 0.01% |
447,264
+5,017
| +1% | +$195K |
|
738
Canadian National Railway
CNI
$57.9B
| $17.4M | 0.01% |
163,751
+11,453
| +8% | +$1.22M |
|
739
Paycom
PAYC
$12.7B
| $17.3M | 0.01% |
55,590
-23,367
| -30% | -$7.27M |
|
|
DCPH
740
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $17.2M | 0.01% |
335,306
+304
| +0.1% | +$15.6K |
|
741
Kiniksa Pharmaceuticals
KNSA
$2.7B
| $17.1M | 0.01% |
+1,118,261
| New | +$17.1M |
|
742
Medical Properties Trust
MPW
$2.77B
| $17.1M | 0.01% |
970,893
-385,265
| -28% | -$6.79M |
|
743
Franco-Nevada
FNV
$38.7B
| $16.9M | 0.01% |
121,636
-89,515
| -42% | -$12.5M |
|
744
Mersana Therapeutics
MRSN
$37.2M
| $16.9M | 0.01% |
36,354
+34,059
| +1,484% | +$15.9M |
|
745
Idexx Laboratories
IDXX
$51.6B
| $16.7M | 0.01% |
42,527
-47,905
| -53% | -$18.8M |
|
746
Montrose Environmental
MEG
$1.07B
| $16.7M | 0.01% |
+700,646
| New | +$16.7M |
|
747
Atmos Energy
ATO
$26.5B
| $16.6M | 0.01% |
174,097
-91,975
| -35% | -$8.79M |
|
748
Novo Nordisk
NVO
$241B
| $16.6M | 0.01% |
479,108
+48,422
| +11% | +$1.68M |
|
749
Factset
FDS
$13.9B
| $16.6M | 0.01% |
49,570
+18,043
| +57% | +$6.04M |
|
750
Melco Resorts & Entertainment
MLCO
$3.83B
| $16.6M | 0.01% |
994,555
-9,851
| -1% | -$164K |
|